The signal is AC coupled so I don't "need" the DC coupling availability of FDAs. I don't need another gain stage either, so the FDA would be in a 0dB gain configuration.
My main concern is one of my requirements is to have below 7-9 nV/rt-Hz output noise, all stages included. A single differential amplifier stage is going to have 4-6 nV/rt-Hz output noise from resistors alone (if I choose low values,) plus the ~1nV/rt-Hz injected from the differential amplifier itself.
My understanding is that transformer baluns offer superior amplitude and phase balance, lower noise injection (if any,) so in my application where SNR is everything I can see why it would be the choice. Look at the AD9655 app notes, they say to use a balun rather than an FDA.
Meanwhile an RF FDA such like the LMH6554 would offer extra common mode noise immunity (the only benefit???) and inject unwanted noise into the signal, degrading SNR.
Another point of confusion for me is the author of this article claims that FDAs will have "better" balance error and distortion specifications. In terms of balance error, the transformer I'm going to use (https://cdn.macom.com/datasheets/ETC1-1-13.pdf) specifies a 1dB amplitude balance and +/- 20 degree phase balance, while the LMH6554 specifies a balance error of -64dB. How do I compare these specifications to decide whether the balun or FDA will create a more "balanced" differential signal.
https://e2e.ti.com/blogs_/b/analogwire/posts/driving-adcs-amplifier-or-balun
Questions:
- Why are baluns preffered to FDAs at RF frequencies for driving a differential ADC?
- Are there any benefits to FDAs besides CMRR?
- Is it logical to compare the amplitude and phase balance of my transformer to the balance error of the differential amplifier? Can you convert between those specifications?
- Is there any other way to increase CMRR of a differential ADC front end without adding a differential amplifier?